nodes	percent_of_prediction	percent_of_DWPC	metapath
Alimemazine—CYP3A4—Cytarabine—lymphatic system cancer	0.241	0.318	CbGbCtD
Alimemazine—CYP3A4—Teniposide—lymphatic system cancer	0.237	0.313	CbGbCtD
Alimemazine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.166	0.219	CbGbCtD
Alimemazine—CYP3A4—Vincristine—lymphatic system cancer	0.114	0.151	CbGbCtD
Alimemazine—Consciousness abnormal—Vincristine—lymphatic system cancer	0.0299	0.124	CcSEcCtD
Alimemazine—Amenorrhoea—Mechlorethamine—lymphatic system cancer	0.0149	0.0616	CcSEcCtD
Alimemazine—Pallor—Teniposide—lymphatic system cancer	0.0117	0.0482	CcSEcCtD
Alimemazine—Altered state of consciousness—Vincristine—lymphatic system cancer	0.0112	0.0464	CcSEcCtD
Alimemazine—Jaundice—Mechlorethamine—lymphatic system cancer	0.00715	0.0295	CcSEcCtD
Alimemazine—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.00685	0.0283	CcSEcCtD
Alimemazine—Amenorrhoea—Mitoxantrone—lymphatic system cancer	0.00575	0.0238	CcSEcCtD
Alimemazine—Gynaecomastia—Carmustine—lymphatic system cancer	0.00487	0.0201	CcSEcCtD
Alimemazine—Infection—Mechlorethamine—lymphatic system cancer	0.00465	0.0192	CcSEcCtD
Alimemazine—Arrhythmia—Teniposide—lymphatic system cancer	0.00434	0.0179	CcSEcCtD
Alimemazine—Agitation—Teniposide—lymphatic system cancer	0.00388	0.016	CcSEcCtD
Alimemazine—Arrhythmia—Fludarabine—lymphatic system cancer	0.00381	0.0157	CcSEcCtD
Alimemazine—Hypokalaemia—Carmustine—lymphatic system cancer	0.00359	0.0148	CcSEcCtD
Alimemazine—Infection—Teniposide—lymphatic system cancer	0.00343	0.0142	CcSEcCtD
Alimemazine—Agitation—Fludarabine—lymphatic system cancer	0.00341	0.0141	CcSEcCtD
Alimemazine—Hypokalaemia—Mitoxantrone—lymphatic system cancer	0.00334	0.0138	CcSEcCtD
Alimemazine—Hypotension—Teniposide—lymphatic system cancer	0.00322	0.0133	CcSEcCtD
Alimemazine—Convulsion—Fludarabine—lymphatic system cancer	0.00322	0.0133	CcSEcCtD
Alimemazine—Infection—Fludarabine—lymphatic system cancer	0.00301	0.0124	CcSEcCtD
Alimemazine—Erectile dysfunction—Vincristine—lymphatic system cancer	0.003	0.0124	CcSEcCtD
Alimemazine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00297	0.0123	CcSEcCtD
Alimemazine—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00297	0.0123	CcSEcCtD
Alimemazine—Rash—Mechlorethamine—lymphatic system cancer	0.00295	0.0122	CcSEcCtD
Alimemazine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00295	0.0122	CcSEcCtD
Alimemazine—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00292	0.0121	CcSEcCtD
Alimemazine—Jaundice—Mitoxantrone—lymphatic system cancer	0.00276	0.0114	CcSEcCtD
Alimemazine—Body temperature increased—Teniposide—lymphatic system cancer	0.00273	0.0113	CcSEcCtD
Alimemazine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00264	0.0109	CcSEcCtD
Alimemazine—Arrhythmia—Carmustine—lymphatic system cancer	0.00244	0.0101	CcSEcCtD
Alimemazine—Cardiac disorder—Vincristine—lymphatic system cancer	0.00242	0.00999	CcSEcCtD
Alimemazine—Body temperature increased—Fludarabine—lymphatic system cancer	0.0024	0.0099	CcSEcCtD
Alimemazine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00227	0.00937	CcSEcCtD
Alimemazine—Gynaecomastia—Methotrexate—lymphatic system cancer	0.00225	0.00931	CcSEcCtD
Alimemazine—Tremor—Carmustine—lymphatic system cancer	0.00223	0.0092	CcSEcCtD
Alimemazine—Infection—Bleomycin—lymphatic system cancer	0.00221	0.00912	CcSEcCtD
Alimemazine—Agitation—Carmustine—lymphatic system cancer	0.00218	0.00902	CcSEcCtD
Alimemazine—Rash—Teniposide—lymphatic system cancer	0.00217	0.00898	CcSEcCtD
Alimemazine—Dermatitis—Teniposide—lymphatic system cancer	0.00217	0.00897	CcSEcCtD
Alimemazine—Agitation—Vincristine—lymphatic system cancer	0.00209	0.00861	CcSEcCtD
Alimemazine—Photosensitivity—Methotrexate—lymphatic system cancer	0.00208	0.0086	CcSEcCtD
Alimemazine—Hypotension—Bleomycin—lymphatic system cancer	0.00208	0.00858	CcSEcCtD
Alimemazine—Convulsion—Carmustine—lymphatic system cancer	0.00206	0.00851	CcSEcCtD
Alimemazine—Convulsion—Vincristine—lymphatic system cancer	0.00197	0.00812	CcSEcCtD
Alimemazine—Infection—Carmustine—lymphatic system cancer	0.00193	0.00796	CcSEcCtD
Alimemazine—Convulsion—Mitoxantrone—lymphatic system cancer	0.00191	0.00791	CcSEcCtD
Alimemazine—Rash—Fludarabine—lymphatic system cancer	0.00191	0.00789	CcSEcCtD
Alimemazine—Dermatitis—Fludarabine—lymphatic system cancer	0.00191	0.00789	CcSEcCtD
Alimemazine—Infection—Vincristine—lymphatic system cancer	0.00184	0.0076	CcSEcCtD
Alimemazine—Nervous system disorder—Vincristine—lymphatic system cancer	0.00182	0.0075	CcSEcCtD
Alimemazine—Hypotension—Carmustine—lymphatic system cancer	0.00181	0.00749	CcSEcCtD
Alimemazine—Infection—Mitoxantrone—lymphatic system cancer	0.00179	0.0074	CcSEcCtD
Alimemazine—Body temperature increased—Bleomycin—lymphatic system cancer	0.00176	0.00726	CcSEcCtD
Alimemazine—Insomnia—Carmustine—lymphatic system cancer	0.00175	0.00725	CcSEcCtD
Alimemazine—Hypotension—Vincristine—lymphatic system cancer	0.00173	0.00715	CcSEcCtD
Alimemazine—Hypotension—Mitoxantrone—lymphatic system cancer	0.00169	0.00696	CcSEcCtD
Alimemazine—Insomnia—Vincristine—lymphatic system cancer	0.00168	0.00692	CcSEcCtD
Alimemazine—Eosinophilia—Methotrexate—lymphatic system cancer	0.00156	0.00646	CcSEcCtD
Alimemazine—Body temperature increased—Carmustine—lymphatic system cancer	0.00153	0.00633	CcSEcCtD
Alimemazine—Body temperature increased—Vincristine—lymphatic system cancer	0.00146	0.00605	CcSEcCtD
Alimemazine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00146	0.00601	CcSEcCtD
Alimemazine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00144	0.00596	CcSEcCtD
Alimemazine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00143	0.00589	CcSEcCtD
Alimemazine—Rash—Bleomycin—lymphatic system cancer	0.0014	0.00579	CcSEcCtD
Alimemazine—Dermatitis—Bleomycin—lymphatic system cancer	0.0014	0.00578	CcSEcCtD
Alimemazine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00131	0.00543	CcSEcCtD
Alimemazine—Rash—Carmustine—lymphatic system cancer	0.00122	0.00505	CcSEcCtD
Alimemazine—Dermatitis—Carmustine—lymphatic system cancer	0.00122	0.00505	CcSEcCtD
Alimemazine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00117	0.00485	CcSEcCtD
Alimemazine—Rash—Vincristine—lymphatic system cancer	0.00117	0.00482	CcSEcCtD
Alimemazine—Dermatitis—Vincristine—lymphatic system cancer	0.00117	0.00482	CcSEcCtD
Alimemazine—Rash—Mitoxantrone—lymphatic system cancer	0.00114	0.0047	CcSEcCtD
Alimemazine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00114	0.00469	CcSEcCtD
Alimemazine—Convulsion—Methotrexate—lymphatic system cancer	0.000954	0.00394	CcSEcCtD
Alimemazine—Infection—Methotrexate—lymphatic system cancer	0.000893	0.00369	CcSEcCtD
Alimemazine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000881	0.00364	CcSEcCtD
Alimemazine—Hypotension—Methotrexate—lymphatic system cancer	0.00084	0.00347	CcSEcCtD
Alimemazine—Insomnia—Methotrexate—lymphatic system cancer	0.000813	0.00336	CcSEcCtD
Alimemazine—Body temperature increased—Methotrexate—lymphatic system cancer	0.00071	0.00293	CcSEcCtD
Alimemazine—Rash—Methotrexate—lymphatic system cancer	0.000567	0.00234	CcSEcCtD
Alimemazine—Dermatitis—Methotrexate—lymphatic system cancer	0.000566	0.00234	CcSEcCtD
